Skip to content

A multi center randomized controlled trial of acupoint therapy for refractory sudden deafness of deep needling of Shaoyang

A multi center randomized controlled trial of acupoint therapy for refractory sudden deafness of deep needling of Shaoyang

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012835
Enrollment
Unknown
Registered
2017-09-29
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden sensorineural hearing loss

Interventions

Deep needling:Deep needling and oral Chinese medicine
General acupuncture group:General acupuncture and oral Chinese medicine
Oral Chinese medicine group:Oral Chinese Medicine

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 70 years old, men and women; (2) meet the diagnostic criteria; (3) for the first time, the onset time was less than 2-4 weeks, and all the patients with sudden deafness who had not recovered were treated with western medicine, such as glucocorticoids; (4) receiving acupuncture treatment; (5) conscious, able to cooperate with inspection and treatment; (6) the subjects were willing to take part in the study and sign informed consent after they read the informed consent.

Exclusion criteria

Exclusion criteria: (1) women in menstrual period, pregnant women and lactating women; (2) due to various reasons such as work, time, family and so on, we can not cooperate with the researcher; (3) sudden deafness accompanied by severe depression and anxiety; (4) suffering from severe mental illness and not having the ability to act; (5) serious heart, brain, kidney and other complications, severe hypertension, diabetes, digestive system diseases, tuberculosis, hyperlipidemia; (6) excluding congenital, traumatic, middle ear lesions, Meynier's disease, acoustic neuroma and so on; (7) unable to receive acupuncture treatment.

Design outcomes

Primary

MeasureTime frame
pure tone audiometry;Acoustic impedance test;Tinnitus determination;Tinnitus disability scale;

Secondary

MeasureTime frame
VAS;Pittsburgh sleep quality index (PSQI);Self rating Anxiety Scale (SAS);Hamilton Anxiety Scale (HAMA);Vertigo disorder scale;Vertigo clinical symptom rating scale;

Countries

China

Contacts

Public ContactSong Hongmei

Chengdu University of TCM

jianshejiancha@vip.sina.com+86 15982307269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026